Tag Archives: Viral Vectors and Plasmid DNA Manufacturing Market

The viral vectors and plasmid DNA manufacturing market is projected to expand at a CAGR of 22.5%, during the period from 2023 to 2031, propelled by the rising demand for advanced gene therapies, vaccines, and cell therapies. With a potential compound annual growth rate (CAGR), the market’s revenue is expected to increase significantly over the next few years. In the ...